American Century Companies Inc Catalyst Pharmaceuticals, Inc. Transaction History
American Century Companies Inc
- $157 Billion
- Q1 2025
A detailed history of American Century Companies Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 526,569 shares of CPRX stock, worth $11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
526,569
Previous 157,409
234.52%
Holding current value
$11 Million
Previous $3.29 Million
288.71%
% of portfolio
0.01%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CPRX
# of Institutions
385Shares Held
99.7MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$391 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$116 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$71.5 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$65.5 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.15B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...